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Abstract: Cardiovascular disease is a worldwide human condition which has multiple underlying
contributing factors: one of these is long-term increased blood pressure—hypertension. Nitric oxide
(NO) is a small nitrogenous radical species that has a number of physiological functions including
vasodilation. It can be produced enzymatically through host nitric oxide synthases and by an
alternative nitrate–nitrite–NO pathway from ingested inorganic nitrate. It was discovered that this
route relies on the ability of the oral microbiota to reduce nitrate to nitrite and NO. Next generation
sequencing has been used over the past two decades to gain deeper insight into the microbes involved,
their location and the effect of their removal from the oral cavity. This review article presents this
research and comments briefly on future directions.
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1. Introduction
Oral microbiota are the second most complex niche of the human microbiome [1]; they have been
associated with several non-communicative diseases, including cancer [2], Alzheimer’s disease [3] and
cardiovascular disease (CVD) [4,5]. The current review will focus on the association between the oral
microbiota and the most well established mechanistic pathway through which the oral microbiota may
modify CVD, namely via the nitric oxide (NO) synthesis pathway.
In Europe, 3.9 million people die yearly from CVD, costing about 210 billion Euros per year in
healthcare costs, productivity losses and informal care [6]. Hypertension is an important subclinical
parameter for cardiovascular disease—about 54% of all stroke and 47% of ischemic heart disease are
attributed to hypertension [7]. Hypertension is defined by WHO as systolic blood pressure ≥140 mm
Hg and diastolic pressure ≥90, however it was recently reported that the definition of hypertension
needs to be re-visited as lowering systolic blood pressure not to under 140 mm Hg, but to 120 mm Hg
causes less fatal and non-fatal cardiovascular events. This also suggests that hypertension may be
more important in CVD than previously described [8].
There are several important mechanisms behind hypertension, but one key underpinning is the
L-arginine/NO synthesis pathway. In addition to hypertension, the NO synthesis pathway is important
in the pathobiology of CVD via inflammation and platelet activation and aggregation [9].
2. The L-Arginine/NO Synthesis Pathway
In 1998, Robert F. Furchgott, Louis J. Ignarro and Ferid Murad were awarded the Nobel Prize for
detecting and describing L-arginine/NO synthesis in cardiovascular physiology and disease. Furchgott
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described the accidental finding that acethylcholine, bradykinin, histamine and 5-hydroxytryptamine
relax isolated preparations of blood vessels, but only when the endothelium is intact. In rabbit
thoracic aorta prepared as a transverse ring, acetylcholine stimulation with muscarinic agonists caused
dilatation, but not in aorta prepared as a helical strip. Later, it was noted that gently rubbing the
endothelium of the transverse ring preparations similarly caused loss of smooth muscle cell relaxation.
The endothelium-derived factor relaxing the smooth muscle cells lining the arteries was named
endothelium-derived relaxing factor (EDRF) [10,11].
Following the discovery of EDRF, there was a wave of research inhibiting EDRF. What these
inhibitors all had in common was their redox potency, except hemoglobin which inactivated EDRF
by binding to it. This led to the suggestion that EDRF might be a free radical [12,13], and eventually
Ignarro et al. [14] suggested that EDRF may in fact be NO, which at that time was not known to be
synthesized in humans.
Then the question was where NO originates from, and in macrophages it was shown that NO
originates from L-arginine [15,16]. Later, the enzyme responsible for the conversion of L-arginine to
NO was identified as NO synthase. In addition to macrophages, NO was discovered in the central
nervous system [17]. Depending on the system, different isoforms of NO synthase were identified,
namely eNOS in endothelial cells, nNOS in the nervous system, and iNOS in the inflammatory system.
The inhibition of L-arginine and knockdown of eNOS in animal models led to the paradigm
shift that hypertension is not due to increased resistance, but due to decreased conductance in the
vascular system. The eNOS knockout mice also had increased endothelial-leucocyte interaction,
platelet aggregation and thrombosis [18]. When knocking down eNOS in hypercholesterolemic ApoE
mice, the eNOS-deficient mice had accelerated atherosclerosis [19]. Taken together, this work showed
that the importance of eNOS and the L-arginine/NO synthesis pathway goes far beyond hypertension.
In fact, NO from the eNOS activity of endothelial cells not only causes less contractility of the smooth
muscle cells, but also results in inhibition of activation, adhesion and aggregation of platelets, less
adhesivity of leucocytes and enhanced oxygen delivery from erythrocytes [20].
In 1986, Ludmer and coworkers [21] published a now classical study showing that in subjects
with known CVD, acetylcholine resulted in a paradoxical NO-mediated vasoconstriction, in contrast
to vasodilation in healthy subjects. Importantly, subjects with minimal CVD (angiographically) also
displayed vasoconstriction. All three groups dilated in response to nitroglycerine. What this study
suggested was that dysfunctional endothelial NO production and availability might precede the
formation of clinically significant atherosclerotic lesions—today known as endothelial dysfunction. The
clinical evaluation of endothelial function is through flow-mediated dilatation (FMD), today known as
a subclinical predictor of CVD events [22] which is impaired in known CVD high risk groups, such as
smokers and subjects with hypocholesteremia [23].
Endothelial dysfunction affects the L-arginine/NO-synthesis in two important ways—on a cellular
level and on a molecular level. Endothelial cells can undergo phenotypical changes from healthy to a
pro-inflammatory cell type. Healthy conditions, such as laminar blood flow, cause upregulation of
transcription factors, such as Kruppel-like factors (KLF) 2 and 4, whereas athero-promoting flow and
pro-inflammatory content of the blood cause upregulation of NFkB, eliciting a pro-inflammatory cell
phenotype [24,25]. KLF2 promotes anti-CVD mechanisms, such as anti-inflammation by inhibiting the
NFkB pathway [26,27], and anti-thrombogenic by inducing eNOS and thrombomodulin and reducing
plasminogen activator inhibitor (PAI-1) [28]. Interestingly, KLF2 can be induced pharmacologically,
via statins that exert atheroprotective effects via KLF2 [29]. NFkB is a pro-inflammatory transcription
factor causing recruitment and activation of leucocytes at the site and subsequent endothelial
dysfunction [24,25]. On a molecular level, the inflammatory micro-environment at an atherosclerotic
lesion causes a net excess of reactive oxygen species (ROS), including superoxide which inactivates
NO by forming peroxynitrite which could result in DNA damage and protein modification, but also
through uncoupling of eNOS [30].
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3. Microbiome Contributions to NO Synthesis
Research in the mid-1990s showed that NO production can be independent of NOS [31–33]. This
production was linked directly to diet as, for example, nitrate-rich vegetable consumption could
increase systemic nitrate and result in lowering of systolic blood pressure [34]. However, the activation
of nitrate and transformation ultimately to NO requires its conversion to nitrite and mammals lack
the enzymes required for this bioactivation. Termed the entero-salivary circulation, this requires
consumption of nitrate which is absorbed by the upper gastrointestinal tract (Figure 1). Nitrate in
circulation (approximately 25%, the remainder being secreted by the kidneys) is then selectively
acquired by the sialin protein in the salivary glands and thus a high concentration of nitrate (1500 µM)
is returned to the oral cavity [35]. There, the conversion of nitrate to nitrite is carried out by the
oral microbiota [36]. Upon entering the stomach, the nitrite is protonated to nitrous acid (HNO2)
which can then decompose to NO and other oxides. The following section reviews the results from
next generation sequencing approaches to understanding more about the bacteria involved in the
conversion of nitrate to nitrite in the oral cavity.
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The first study examining the oral microbiota and the constituent microbes involved in nitrate
and nitrite reduction was published in 2005 [36]. By mapping nitrate reduction across the mouth,
Doel et al. could demonstrate that the majority of nitrate reductase activity was associated with the
dorsum of the tongue. Indeed, the tongue dorsum has a distinct microbiome which is related to the
other oral niches. It is more similar to the saliva microbiome than to the oral plaque microbiomes
(Human microbiome project consortium 2012 [37]). They went further by isolating and culturing
species associated within this site and verifying nitrate reductase activity. More species were found
to have this activity under anaerobic conditions than aerobic conditions. Isolates of interest were
16S rRNA sequenced to gain their identity. The highest levels of nitrate reduction were found with
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Actinomyces odontolytica which was the second most common tongue isolate, though the authors also
detected Veillonella atypica, Veillonella dispar, Veillonella parvula, Actinomyces naeslundii, Actinomyces
viscosus, Rothia dentocariosa, Rothia mucilaginosa, Staphylococcus epidermidis, Staphylococcus hemolyticus,
Corynebacterium matruchotii, Corynebacterium durum, Haemophilus parainfluenzae, Haemophilus segnis,
Propionibacterium acnes, Granulicatella adiacens, Selenomonas noxia, Capnocytophaga sputigena, Eikinella
corrodens and Microbacterium oxydans. The next report showing the microbiome associated with nitrate
reduction was published a decade later, once the metagenomics analysis tools had matured more fully.
Hyde et al. [4] used 16S rRNA and whole genome analysis of whole tongue scrapings and of biofilms
originated from the scrapings matured on polymethacrylate (PMMA) discs for up to 4 days. The
change in technique from Doel et al. [36] allowed for a larger number of operational taxonomic units
(OTUs) to be discovered and a wider range of genera: Streptococcus, Veillonella, Prevotella, Neisseria and
Haemophilus. The authors noted that there was a wide variation between different donors. With the
samples that were used to inoculate biofilms, it was also noted that the number of OTUs dropped
dramatically within the first 24 h and that by 4 days the biofilms were dominated by the Streptococcal
species. Koopman et al. [38] also demonstrated this loss of diversity when growing saliva samples
in a nitrate-reducing bacteria discovery study. This is of interest in light of the report by Doel et al.
where culturing was used to find the nitrate-reducing bacteria before sequencing as this may have
resulted in under-estimation of the discoveries. With the whole genome sequencing and pathway
analysis, by Hyde et al., the pathways associated with the samples were more consistent with a match
across the top eight pathways, such as various amino acid metabolic or synthetic pathways and
nitrogen metabolism. Hyde et al. also split their results into samples with high, intermediate and low
nitrate reductase activity: these samples were derived from the inoculated biofilms and were derived
from individual donors creating a dataset of 30. Using principal coordinate analysis (PCoA), they
showed that the samples with high nitrate reduction capacity were more likely to contain Granulicatella,
Veillonella, Neisseria, Actinomyces, Prevotella, Haemophilus, Fusobacterium and some unclassified species
of the Gemellaceae family. Some of these were already known whilst others were novel. Of note was the
fact that Lactobacillus was associated with the least nitrate-reducing samples and the authors speculated
that these genera may have an inhibitory role through production of some unknown byproduct that
may inhibit nitrate reduction in those communities. Last, these authors also grew four microorganisms
with putative nitrate and/or nitrite reduction capacity: A. odontolyticus, V. dispar, F. nucleatum and
S. mutans. This last aspect of their study showed that these species could work independently or in a
consortium to effectively remove nitrate and/or nitrite from growth medium. This is an important
illustration of the complex interdependent networks in which biofilms exist. This paper not only
confirmed previous findings but took them a step further, however both studies relied on discoveries
from only 10 and 6 tongue scraping donors.
Hyde et al. [39] also published an article characterizing the tongue microbiome of rats, in
comparison to human tongue scrapings, with a focus on the effect of dietary nitrate. One of the main
findings was that the rat tongue microbiome was less diverse and appeared to be missing or had a
greatly decreased amount of Veillonella, Prevotella, Neisseria and Porphyromonas in comparison to human
samples. However, one of the limitations of the study was that different methodologies were used
between the rat and human samples. Nevertheless, they could also examine the effect of administration
of sodium nitrate via drinking water and chlorhexidine via oral rinse. The supplementation by
sodium nitrate significantly decreased diastolic blood pressure and heart rate and made non-significant
decreases in systolic blood pressure and mean arterial pressure. These changes were associated with
relative increases in tongue Haemophilus species and Streptococcus species, which are nitrate and nitrite
reducers, respectively. The change in the microbiome had not previously been demonstrated but
later Koopman et al. [38] used a saliva inoculum from two human donors to create microcosms in
the multiplaque artificial mouth (MAM) biofilm model system and to examine the effect of nitrate
supplementation on the resultant microcosms. For one donor, Neisseria were associated with the
nitrate-treated microcosms whereas Veillonella was more associated with nitrate treatment in the
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microcosms from the other donor. As both these genera seem to be missing from the rat tongue
microbiome and this human study used saliva, it is difficult to draw a conclusion from a comparison of
these experiments.
Chlorhexidine can abolish the effect of sodium nitrate supplementation [34,40–42] and
Hyde et al. [39,43] showed that its use as a mouth rinse in rats decreased Haemophilus, Aggregaterbacter,
and Micrococcaceae but increased Enterobacteriaceae, Corynebacterium and Morganella with the overall
effect being an increase in diversity through a change in low abundance taxa in the baseline samples.
Unfortunately, the chlorhexidine oral rinse did not change the blood pressure or heart rate measures as
expected and the authors concluded that it did not remain in the mouth for long enough to exert the
intended effect.
Recently, attention has turned towards responses in a wider range of donors. Vanhatalo et al. [43]
examined the oral microbiome in young and old healthy donors and the response of these microbiomes
to supplementation using a crossover design with either a high nitrate beetroot drink or placebo
nitrate depleted over 10 days each. The supplementation of the high nitrate beetroot juice increased
plasma nitrate to a similar extent whereas nitrite increases were greater for older participants. Mean
arterial pressure, systolic blood pressure and diastolic blood pressure all showed a greater decrease
with age and nitrite dose. Overall, they showed high quantities of Fusobacterium nucleatum nucleatum,
Prevotella melaninogenica, Campylobacter concisus, Leptotrichia buccalis, Veillonella parvula, Prevotella
intermedia, Fusobacterium nucleatum vincentii and Neisseria meningitidis in the tongue swabs. Changes
in the oral microbiome were assessed in saliva samples before and after nitrate supplementation:
supplementation changed the oral microbial communities but age did not and diversity was similar
across the categories. Fifty-two taxonomic units were significantly changed with supplementation:
Veillonella and Prevotella decreased, whereas Neisseria increased and there was no observed change in
Campylobacter or Haemophilus. Burleigh et al. [44] studied the effect of nitrate-rich beetroot juice or
nitrate-depleted placebo supplementation on the tongue microbiome and how the altered microbiome
responded to an acute dose of nitrate. As seen before, there were decreases in Prevotella, Streptococcus
and Actinomyces and an increase in Neisseria with supplementation. For the acute dose, saliva and
plasma nitrate and nitrite were measured 1.5 h and 2.5 h, respectively, after nitrate consumption
both before and after 7 days of supplementation. At both time points, there was an increase in
nitrate and nitrite in both compartments but the alteration of the microbiome by 7 days of beetroot
juice consumption did not alter the maximal nitrite and nitrate concentrations after the acute dose.
The authors suggest that excess nitrite may be rapidly excreted to prevent excessive drops in blood
pressure, or that the change in the nitrate/nitrite-reducing genera (Prevotella and Actinomyces) may
balance the overall capacity of the system.
Kapil et al. [45] explored the influence of gender on nitrate reduction and the oral microbiota.
Female participants had higher saliva, plasma and urine nitrite levels than males, and after
supplementation with inorganic nitrate they showed a greater increase in plasma nitrate. However,
there was no difference between the composition of the salivary microbiota of male and female
participants. Ashworth et al. [46] considered the difference in the oral microbiome and dietary intake
of inorganic nitrate between vegetarians and omnivores, as previously it was suggested that vegetarian
diets are associated with lower blood pressure [47] and this is associated with higher nitrate intake [48].
By using dietary questionnaires, they demonstrated no difference in the consumption of nitrate and
that saliva and plasma levels of nitrate and nitrite were similar between the two groups. The oral
microbiome was similar between the two groups. The authors also administered a chlorhexidine
mouth rinse intervention for 7 days and this caused a decrease in diversity in both groups and a drop
in nitrate-reducing bacteria in both groups. Thus, this study suggested no differences in macrodiet and
oral microbiome. This is in contrast to previous studies [49–51] which could be due to differences in
the individuals examined across studies.
Tribble et al. [52] described the effect of tongue cleaning on the tongue microbiome and nitrate
levels. Tongue cleaning is a technique that has been used for the removal of oral malodor or halitosis
J. Clin. Med. 2019, 8, 1110 6 of 9
that is often ascribed to the tongue coating [53]. In this study, orally and systemically healthy oral
health professionals were followed over the course of eleven days during which samples (tongue
scrapings and saliva) were taken at baseline, at 7 days after use of the chlorhexidine mouth rinse and
after a further 3 and 7 days after recovery from use of the mouth rinse. Chlorhexidine caused an
increase in systolic blood pressure in the range of 5 mm/Hg which is equivalent to manipulation of
dietary salt intake [54], however the donors were also stratified by the frequency of tongue cleaning as
either none, once or twice per day. For those participants cleaning their tongue twice per day, there
was the greatest increase in systolic blood pressure after the use of chlorhexidine. When examining
the tongue microflora, the most common operational taxonomic unit was Haemophilus parainfluenzae
and the second Neisseria subflava. However, the most common genus changed between individuals
with groups of Neisseria, Prevotella and Leptotrichia as the most common. The frequency of tongue
cleaning changed the abundance of species found: for example, Leptotrichia spp were detected in higher
abundance on tongues that were not cleaned and daily cleaning (either once or twice) increased the
abundance of H. parainfluenzae found. This showed that the tongue microbiome when tongue cleaning
was implemented has a greater nitrate reductase capability. However, chlorhexidine treatment did
not cause large-scale changes in the microbiome community. Further exploration suggested that any
changes that occur are transient, with the recovery phase being associated with an increase in bacterial
metabolic activity.
Box 1: Definitions:
• 16S rRNA is part of the bacterial ribosome, assigning structural scaffolding, and is of interest in
the phylogenetic assignment of bacteria due to its slow rate of evolution.
• OTUs (operational taxonomic units) group together closely related individuals when individuals
cannot be distinguished by the data available.
• Biofilms are embedded collections of microorganisms growing together in a matrix of extracellular
polymeric substances on a surface.
• Next generation sequencing describes a wide range of DNA sequencing technologies capable of
sequencing millions of fragments of DNA in parallel.
• Whole genome analysis sequences the whole of one or more genomes rather than a single gene, as
with 16S rRNA analysis.
• Microbiome defines all of the microbial genomes in a given sample or environment.
• Microbiota defines the entire microbial flora in a given sample or environment.
• Principal coordinate analysis (PCoA) is a multivariate statistical technique used to reduce
dimensions in data analysis and allowed for representation of the data visually.
4. Concluding Remarks
Overall, these next generation sequencing studies have demonstrated that there are nitrate and
nitrite-reducing bacteria found in the mouth and that their removal through mouth rinsing with
chlorhexidine will cause a temporary increase in blood pressure. The microbes most often found in
the studies were from Actinomyces, Haemophilus, Neisseria and Veillonella genera. Samples have been
from the tongue dorsum, where nitrate-reducing species were first identified, and also in saliva which
may be easier to collect. The microbiomes of these two compartments are distinct but closely related.
Furthermore, saliva indeed bathes the tongue, thereby enabling that microbiome to be sampled. More
recent studies are just beginning to report [43–46,52] on how the microbiota in both the tongue dorsum
and saliva change with different conditions, as previously only samples from homogeneous and healthy
donors have been described. The number of donors in each study is also rising, helped by decreases in
the costs of these types of experiments, which will help to gain more generalizable data and data that
may reveal more subtle nuances between diseases types, ethnicities and other characteristics. This
review has highlighted the role of the oral microbiota in the conversion of nitrate to nitrite and its
importance to systemic balance. Understanding more about the role that the oral microbiota can play
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will enable future interventions that may aid with a stratified medicine approach that may rely more
on bolstering the useful oral microflora and potentially reduce the use of antimicrobials.
Author Contributions: M.M.G. and D.J. Writing—Original draft, review and editing.
Funding: Daniel Jönsson’s research time is sponsored by Swedish Dental Service of Skåne and Oral Health Related
Research by Region Skåne.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Deo, PN.; Deshmukh, R. Oral microbiome: Unveiling the fundamentals. J. Oral Maxillofac. Pathol. 2019, 23,
122–128. [PubMed]
2. Chen, J.; Domingue, J.C.; Sears, C.L. Microbiota dysbiosis in select human cancers: Evidence of association
and causality. Semin. Immunol. 2017, 32, 25–34. [CrossRef] [PubMed]
3. Dominy, S.S.; Lynch, C.; Ermini, F.; Benedyk, M.; Marczyk, A.; Konradi, A.; Nguyen, M.; Haditsch, U.;
Raha, D.; Griffin, C.; et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease
causation and treatment with small-molecule inhibitors. Sci. Adv. 2019, 5, eaau3333. [CrossRef] [PubMed]
4. Hyde, E.R.; Andrade, F.; Vaksman, Z.; Parthasarathy, K.; Jiang, H.; Parthasarathy, D.K.; Torregrossa, A.C.;
Tribble, G.; Kaplan, H.B.; Petrosino, J.F.; et al. Metagenomic analysis of nitrate-reducing bacteria in the oral
cavity: Implications for nitric oxide homeostasis. PLoS ONE 2014, 9, e88645. [CrossRef] [PubMed]
5. Desvarieux, M.; Demmer, R.T.; Rundek, T.; Boden-Albala, B.; Jacobs, D.R., Jr.; Sacco, R.L.; Papapanou, P.N.
Periodontal microbiota and carotid intima-media thickness: The Oral Infections and Vascular Disease
Epidemiology Study (INVEST). Circulation 2005, 111, 576–582. [CrossRef] [PubMed]
6. Timmis, A.; Townsend, N.; Gale, C.; Grobbee, R.; Maniadakis, N.; Flather, M.; Wilkins, E.; Wright, L.; Vos, R.;
Bax, J.; et al. European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur. Heart J. 2018, 39,
508–579. [CrossRef]
7. Lawes, C.M.; Vander Hoorn, S.; Rodgers, A.; for the International Society of Hypertension. Global burden of
blood-pressure-related disease, 2001. Lancet 2008, 371, 1513–1518. [CrossRef]
8. Group, S.R.; Wright, J.T., Jr.; Williamson, J.D.; Whelton, P.K.; Snyder, J.K.; Sink, K.M.; Rocco, M.V.;
Reboussin, D.M.; Rahman, M.; Oparil, S.; et al. A Randomized Trial of Intensive versus Standard
Blood-Pressure Control. N. Engl. J. Med. 2015, 373, 2103–2116. [CrossRef]
9. Radomski, M.W.; Palmer, R.M.; Moncada, S. An L-arginine/nitric oxide pathway present in human platelets
regulates aggregation. Proc. Natl. Acad. Sci. USA 1990, 87, 5193–5197. [CrossRef]
10. Furchgott, R.F. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived
relaxing factor and its importance in the identification of nitric oxide. JAMA 1996, 276, 1186–1188. [CrossRef]
11. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth
muscle by acetylcholine. Nature 1980, 288, 373–376. [CrossRef] [PubMed]
12. Gryglewski, R.J.; Palmer, R.M.; Moncada, S. Superoxide anion is involved in the breakdown of
endothelium-derived vascular relaxing factor. Nature 1986, 320, 454–456. [CrossRef] [PubMed]
13. Moncada, S.; Palmer, R.M.; Gryglewski, R.J. Mechanism of action of some inhibitors of endothelium-derived
relaxing factor. Proc. Natl. Acad. Sci. USA 1986, 83, 9164–9168. [CrossRef] [PubMed]
14. Ignarro, L.J.; Buga, G.M.; Wood, K.S.; Byrns, R.E.; Chaudhuri, G. Endothelium-derived relaxing factor
produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 1987, 84, 9265–9269.
[CrossRef] [PubMed]
15. Hibbs, J.B., Jr.; Taintor, R.R.; Vavrin, Z. Macrophage cytotoxicity: Role for L-arginine deiminase and imino
nitrogen oxidation to nitrite. Science 1987, 235, 473–476. [CrossRef] [PubMed]
16. Iyengar, R.; Stuehr, D.J.; Marletta, M.A. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines:
Precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 1987, 84, 6369–6373. [CrossRef]
17. Moncada, S.; Palmer, R.M.; Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology.
Pharmacol. Rev. 1991, 43, 109–142.
18. Moncada, S.; Higgs, E.A. The discovery of nitric oxide and its role in vascular biology. Br. J. Pharmacol. 2006,
147 (Suppl. 1), S193–S201. [CrossRef]
J. Clin. Med. 2019, 8, 1110 8 of 9
19. Kuhlencordt, P.J.; Gyurko, R.; Han, F.; Scherrer-Crosbie, M.; Aretz, T.H.; Hajjar, R.; Picard, M.H.; Huang, P.L.
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein
E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104, 448–454. [CrossRef]
20. Gimbrone, M.A., Jr.; Garcia-Cardena, G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis.
Circ. Res. 2016, 118, 620–636. [CrossRef]
21. Ludmer, P.L.; Selwyn, A.P.; Shook, T.L.; Wayne, R.R.; Mudge, G.H.; Alexander, R.W.; Ganz, P. Paradoxical
vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 1986, 315,
1046–1051. [CrossRef] [PubMed]
22. Yeboah, J.; Crouse, J.R.; Hsu, F.C.; Burke, G.L.; Herrington, D.M. Brachial flow-mediated dilation predicts
incident cardiovascular events in older adults: The Cardiovascular Health Study. Circulation 2007, 115,
2390–2397. [CrossRef] [PubMed]
23. Celermajer, D.S.; Sorensen, K.E.; Gooch, V.M.; Spiegelhalter, D.J.; Miller, O.I.; Sullivan, I.D.; Lloyd, J.K.;
Deanfield, J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of
atherosclerosis. Lancet 1992, 340, 1111–1115. [CrossRef]
24. Atkins, G.B.; Simon, D.I. Interplay between NF-kappaB and Kruppel-like factors in vascular inflammation
and atherosclerosis: Location, location, location. J. Am. Heart Assoc. 2013, 2, e000290. [CrossRef] [PubMed]
25. Davies, P.F.; Civelek, M.; Fang, Y.; Fleming, I. The atherosusceptible endothelium: Endothelial phenotypes in
complex haemodynamic shear stress regions in vivo. Cardiovasc. Res. 2013, 99, 315–327. [CrossRef]
26. SenBanerjee, S.; Lin, Z.; Atkins, G.B.; Greif, D.M.; Rao, R.M.; Kumar, A.; Feinberg, M.W.; Chen, Z.; Simon, D.I.;
Luscinskas, F.W.; et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.
J. Exp. Med. 2004, 199, 1305–1315. [CrossRef]
27. Hamik, A.; Lin, Z.; Kumar, A.; Balcells, M.; Sinha, S.; Katz, J.; Feinberg, M.W.; Gerzsten, R.E.; Edelman, E.R.;
Jain, M.K. Kruppel-like factor 4 regulates endothelial inflammation. J. Biol. Chem. 2007, 282, 13769–13779.
[CrossRef]
28. Lin, Z.; Kumar, A.; SenBanerjee, S.; Staniszewski, K.; Parmar, K.; Vaughan, D.E.; Gimbrone, M.A., Jr.;
Balasubramanian, V.; Garcia-Cardena, G.; Jain, M.K. Kruppel-like factor 2 (KLF2) regulates endothelial
thrombotic function. Circ. Res. 2005, 96, e48–e57. [CrossRef]
29. Parmar, K.M.; Nambudiri, V.; Dai, G.; Larman, H.B.; Gimbrone, M.A., Jr.; Garcia-Cardena, G. Statins exert
endothelial atheroprotective effects via the KLF2 transcription factor. J. Biol. Chem. 2005, 280, 26714–26719.
[CrossRef]
30. Forstermann, U.; Xia, N.; Li, H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of
Atherosclerosis. Circ. Res. 2017, 120, 713–735. [CrossRef]
31. Benjamin, N.; O’Driscoll, F.; Dougall, H.; Duncan, C.; Smith, L.; Golden, M.; McKenzie, H. Stomach NO
synthesis. Nature 1994, 368, 502. [CrossRef] [PubMed]
32. Lundberg, J.O.; Weitzberg, E.; Lundberg, J.M.; Alving, K. Intragastric nitric oxide production in humans:
Measurements in expelled air. Gut 1994, 35, 1543–1546. [CrossRef] [PubMed]
33. Zweier, J.L.; Wang, P.; Samouilov, A.; Kuppusamy, P. Enzyme-independent formation of nitric oxide in
biological tissues. Nat. Med. 1995, 1, 804–809. [CrossRef] [PubMed]
34. Webb, A.J.; Patel, N.; Loukogeorgakis, S.; Okorie, M.; Aboud, Z.; Misra, S.; Rashid, R.; Miall, P.; Deanfield, J.;
Benjamin, N.; et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary
nitrate via bioconversion to nitrite. Hypertension 2008, 51, 784–790. [CrossRef] [PubMed]
35. Reimer, R.J. SLC17: A functionally diverse family of organic anion transporters. Mol. Aspects Med. 2013, 34,
350–359. [CrossRef] [PubMed]
36. Doel, J.J.; Benjamin, N.; Hector, M.P.; Rogers, M.; Allaker, R.P. Evaluation of bacterial nitrate reduction in the
human oral cavity. Eur. J. Oral Sci. 2005, 113, 14–19. [CrossRef]
37. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human
microbiome. Nature 2012, 486, 207–214. [CrossRef]
38. Koopman, J.E.; Buijs, M.J.; Brandt, B.W.; Keijser, B.J.; Crielaard, W.; Zaura, E. Nitrate and the Origin of Saliva
Influence Composition and Short Chain Fatty Acid Production of Oral Microcosms. Microb. Ecol. 2016, 72,
479–492. [CrossRef]
39. Hyde, E.R.; Luk, B.; Cron, S.; Kusic, L.; McCue, T.; Bauch, T.; Kaplan, H.; Tribble, G.; Petrosino, J.F.; Bryan, N.S.
Characterization of the rat oral microbiome and the effects of dietary nitrate. Free Radic. Biol. Med. 2014, 77,
249–257. [CrossRef]
J. Clin. Med. 2019, 8, 1110 9 of 9
40. Kapil, V.; Haydar, S.M.; Pearl, V.; Lundberg, J.O.; Weitzberg, E.; Ahluwalia, A. Physiological role for
nitrate-reducing oral bacteria in blood pressure control. Free Radic. Biol. Med. 2013, 55, 93–100. [CrossRef]
41. Bondonno, C.P.; Liu, A.H.; Croft, K.D.; Considine, M.J.; Puddey, I.B.; Woodman, R.J.; Hodgson, J.M.
Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive
men and women. Am. J. Hypertens. 2015, 28, 572–575. [CrossRef] [PubMed]
42. Govoni, M.; Jansson, E.A.; Weitzberg, E.; Lundberg, J.O. The increase in plasma nitrite after a dietary nitrate
load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008, 19, 333–337. [CrossRef]
[PubMed]
43. Vanhatalo, A.; Blackwell, J.R.; L’Heureux, J.E.; Williams, D.W.; Smith, A.; van der Giezen, M.; Winyard, P.G.;
Kelly, J.; Jones, A.M. Nitrate-responsive oral microbiome modulates nitric oxide homeostasis and blood
pressure in humans. Free Radic. Biol. Med. 2018, 124, 21–30. [CrossRef] [PubMed]
44. Burleigh, M.; Liddle, L.; Muggeridge, D.J.; Monaghan, C.; Sculthorpe, N.; Butcher, J.; Henriquez, F.; Easton, C.
Dietary nitrate supplementation alters the oral microbiome but does not improve the vascular responses to
an acute nitrate dose. Nitric Oxide 2019, 89, 54–63. [CrossRef] [PubMed]
45. Kapil, V.; Rathod, K.S.; Khambata, R.S.; Bahra, M.; Velmurugan, S.; Purba, A.; Watson, D.S.; Barnes, M.R.;
Wade, W.G.; Ahluwalia, A. Sex differences in the nitrate-nitrite-NO(*) pathway: Role of oral nitrate-reducing
bacteria. Free Radic. Biol. Med. 2018, 126, 113–121. [CrossRef] [PubMed]
46. Ashworth, A.; Cutler, C.; Farnham, G.; Liddle, L.; Burleigh, M.; Rodiles, A.; Sillitti, C.; Kiernan, M.; Moore, M.;
Hickson, M.; et al. Dietary intake of inorganic nitrate in vegetarians and omnivores and its impact on blood
pressure, resting metabolic rate and the oral microbiome. Free Radic. Biol. Med. 2019, 138, 63–72. [CrossRef]
[PubMed]
47. Yokoyama, Y.; Nishimura, K.; Barnard, N.D.; Takegami, M.; Watanabe, M.; Sekikawa, A.; Okamura, T.;
Miyamoto, Y. Vegetarian diets and blood pressure: A meta-analysis. JAMA Intern. Med. 2014, 174, 577–587.
[CrossRef]
48. Hord, N.G.; Tang, Y.; Bryan, N.S. Food sources of nitrates and nitrites: The physiologic context for potential
health benefits. Am. J. Clin. Nutr. 2009, 90, 1–10. [CrossRef]
49. Mitek, M.; Anyzewska, A.; Wawrzyniak, A. Estimated dietary intakes of nitrates in vegetarians compared to
a traditional diet in Poland and acceptable daily intakes: Is there a risk? Rocz. Panstw. Zakl. Hig. 2013, 64,
105–109.
50. De Filippis, F.; Vannini, L.; La Storia, A.; Laghi, L.; Piombino, P.; Stellato, G.; Serrazanetti, D.I.; Gozzi, G.;
Turroni, S.; Ferrocino, I.; et al. The same microbiota and a potentially discriminant metabolome in the saliva
of omnivore, ovo-lacto-vegetarian and Vegan individuals. PLoS ONE 2014, 9, e112373. [CrossRef]
51. Hansen, T.H.; Kern, T.; Bak, E.G.; Kashani, A.; Allin, K.H.; Nielsen, T.; Hansen, T.; Pedersen, O. Impact of a
vegan diet on the human salivary microbiota. Sci. Rep. 2018, 8, 5847. [CrossRef] [PubMed]
52. Tribble, G.D.; Angelov, N.; Weltman, R.; Wang, B.Y.; Eswaran, S.V.; Gay, I.C.; Parthasarathy, K.; Dao, D.V.;
Richardson, K.N.; Ismail, N.M.; et al. Frequency of Tongue Cleaning Impacts the Human Tongue Microbiome
Composition and Enterosalivary Circulation of Nitrate. Front. Cell. Infect. Microbiol. 2019, 9, 39. [CrossRef]
[PubMed]
53. Quirynen, M.; Dadamio, J.; Van den Velde, S.; De Smit, M.; Dekeyser, C.; Van Tornout, M.; Vandekerckhove, B.
Characteristics of 2000 patients who visited a halitosis clinic. J. Clin. Periodontol. 2009, 36, 970–975. [CrossRef]
[PubMed]
54. Graudal, N.A.; Hubeck-Graudal, T.; Jurgens, G. Effects of low sodium diet versus high sodium diet on blood
pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst. Rev. 2017,
4, CD004022. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
